Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma or urinary bladder: Cause for concern: Editorial comment

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Long-term follow-up in patients treated with methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) for transitional cell carcinoma or urinary bladder: Cause for concern: Editorial comment'. Together they form a unique fingerprint.